Clinical Trial Update: Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating treosulfan, fludarabine phosphate, and total-body irradiation as conditioning for umbilical cord blood transplant in hematolog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia in Remission
• Acute Myeloid Leukemia in Remission
• Biphenotypic Leukemia
• Blasts Under 5 Percent of Bone Marrow Nucleated Cells
• Myelodysplastic Syndrome
• Myelogenous Leukemia Bcr-abl1 Positive
• Phase Chronic Myelogenous Leukemia Bcr-abl1 Positive

Drugs mentioned

• Fludarabine phosphate (Fludarabine phosphate)
• Total Body Irradiation
• Treosulfan (treosulfan)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission | Phase 2 | Status: COMPLETED | Results posted: 2023-02-17